Home › Idiopathic Pulmonary Fibrosis › Wisconsin
Idiopathic Pulmonary Fibrosis clinical trials in Wisconsin
3 studies for Idiopathic Pulmonary Fibrosis are looking for participants at sites in Wisconsin.
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- University of Wisconsin at Madison, Madison
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Sep 15, 2026 · NCT07002034Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)
- UW Health University Hospital, Madison
RecruitingPhase 2
Ages 40 and older · All sexes · Updated Sep 2, 2026 · NCT05571059WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)
- WISPer Site in Wilwaukee, WI, Milwaukee
RecruitingPhase 2
Ages 40 and older · All sexes · Updated Aug 10, 2026 · NCT06967805From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.